Search clinical trials for: Roflumilast Oral Tablet

Total 13692 results

Jazz Pharmaceuticals

Completed

"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy"

Narcolepsy

United States, France, Canada, Germany, Finland, Netherlands
Jazz Pharmaceuticals

Completed

"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA" (OSA)

Obstructive Sleep Apnea

United States, France, Canada, Germany, Netherlands
University Hospital, Grenoble

Unknown

Severe Chronic Respiratory Failure and Citrulline

Pulmonary Disease, Chronic Obstructive

France
Mission Pharmacal

Unknown

Phase II Proof of Concept Study in Uncomplicated UTI

Urinary Tract Infections

United States
Pfizer
Medivation, Inc.

Terminated

An Extension To The B1451006 Protocol To Evaluate The Safety and Efficacy of Dimebon In Subjects With Moderate-to-Severe Alzheimer's Disease

Alzheimer's Disease

United States
Industrial Farmacéutica Cantabria, S.A.
Bioskin GmbH; BioClever 2005 S.L.

Not yet recruiting

Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia

Androgenetic Alopecia | Female Pattern Baldness
Affiliated Cancer Hospital & Institute of Guangzhou...

Unknown

Clinical Pharmacokinetics of TKIs in Chinese Patients of Hepatitis B (HBV)

Hepatitis B | Non Small Cell Lung Cancer

China
University of Tartu

Completed

The Effect of Semaglutide on Pituitary Function

Healthy

Estonia
Chiesi Farmaceutici S.p.A.

Completed

Safety, Tolerability and Efficacy of 28-day Inhaled CHF 6001 DPI in COPD Patients

COPD

United Kingdom, Ireland
Atridia Pty Ltd.

Completed

A Trial of HRS-7085 Tablet in Healthy Participants With and Without Food Effect.

Inflammatory Bowel Disease

Australia
The Lymphoma Academic Research Organisation
Institute of Cancer Research, United Kingdom

Recruiting

Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell Lymphoma

Mantle Cell Lymphoma

France, United Kingdom, Belgium
Handok Inc.

Recruiting

Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin 25 mg and Metformin (TERA 305)

Type 2 Diabetes

Korea, Republic of
Handok Inc.

Recruiting

Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin and Metformin (TERA 304)

Type 2 Diabetes

Korea, Republic of
Amygdala Neurosciences, Inc.

Completed

A Study to Evaluate the Safety of the Coadministration of ANS-6637 and Ethanol

Healthy Volunteers

United States
University of Erlangen-Nürnberg Medical School
Bayer

Recruiting

Finerenone and Renal Oxidative Stress

Type2diabetes

Germany
University of Alabama at Birmingham
Eli Lilly and Company

Not yet recruiting

A Study to Evaluate the Safety and Efficacy of Baricitinib in the Treatment of Frontal Fibrosing Alopecia (FFA)

Frontal Fibrosing Alopecia

United States
Istituto Oncologico Veneto IRCCS

Completed

Regorafenib in Patients With Relapsed Glioblastoma. IOV-GB-1-2020 REGOMA-OSS

Glioblastoma Multiforme

Italy
Rochester Center for Behavioral Medicine

Active, not recruiting

A Trial of Solriamfetol in the Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Chronic Fatigue Syndrome | Myalgic Encephalomyelitis

United States
Oscotec Inc.

Completed

Study of Oral SKI-O-703, SYK Inhibitor, in Patients With Persistent and Chronic Immune Thrombocytopenia (ITP)

Immune Thrombocytopenia

United States, Greece, Korea, Republic of, Poland, Spain
Aminex Therapeutics, Inc.
Iqvia Pty Ltd; Novella Clinical

Withdrawn

Study of Orally-Administered AMXT 1501 Dicaprate in Normal Healthy Volunteers

Neoplasms | Tolerance | Medication Toxicity

United States
Arcutis Biotherapeutics, Inc.

Completed

Long-Term Safety of ARQ-154 Foam in Subjects With Seborrheic Dermatitis

Seborrheic Dermatitis

United States
AstraZeneca
Fougera Pharmaceuticals Inc.

Withdrawn

A Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild to Moderate Plaque Psoriasis

Plaque Psoriasis
Assistance Publique - Hôpitaux de Paris

Terminated

BARIcitinib Cognitive Emotional and Neural signaTuRE (BARICENTRE)

Rheumatoid Arthritis

France
Assistance Publique - Hôpitaux de Paris

Completed

Cobimetinib for BRAF-wild-type or Mutated Histiocytoses (COBRAH)

Disease or R Group Histiocytoses

France
Deciphera Pharmaceuticals LLC

Completed

Phase 3 Study of DCC-2618 vs Placebo in Advanced GIST Patients Who Have Been Treated With Prior Anticancer Therapies (INVICTUS)

Gastrointestinal Stromal Tumors

United States, France, Finland, United Kingdom, Germany, Netherlands, Italy, Belgium, Spain, Canada, Australia, Poland, Singapore
Galapagos NV

Terminated

A Study in Healthy Male Volunteers Investigating the Safety, Absorption and Elimination of Single Doses of GLPG4059

Healthy

Netherlands
Shionogi
QuatRx Pharmaceuticals

Completed

Long-Term Safety of Ospemifene 60 mg Oral Daily Dose for the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women Without a Uterus

Atrophy | Vaginal Diseases
Pfizer

Completed

A First in Human Study to Evaluate Safety, Tolerability, and Pharmacology of PF-06826647 in Healthy Subjects and Subjects With Plaque Psoriasis

Plaque Psoriasis

United States
The University of Texas Health Science Center at...

Withdrawn

Clinical Trial of Roflumilast Added to Standard Chemoimmunotherapy

Lymphoma, B-Cell

United States
AstraZeneca
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 70 y) (APTA-2217-05)

Bronchial Asthma

Japan
Institute of Hematology & Blood Diseases Hospital

Not yet recruiting

Ruxolitinib as GVHD Prophylaxis in AA Patients

The Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA
Chang Gung Memorial Hospital

Recruiting

The Prevalence and Risk Factors for Thyroid Dysfunction in Pregnant Women in Taiwan

Thyroid Disease Pregnancy

Taiwan
Eidos Therapeutics, a BridgeBio company

Completed

Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy (ATTRibute-CM)

Heart Diseases | Amyloidosis | Cardiomyopathies | Transthyretin Amyloidosis | Amyloid Cardiomyopathy

United States, Netherlands, Ireland, Canada, Italy, Spain, Belgium, New Zealand, Israel, Australia, Portugal, Brazil, Poland, Czechia, Denmark, Greece, Korea, Republic of, United Kingdom
Drugs for Neglected Diseases

Completed

Oral Fexinidazole Dosing Regimens for the Treatment of Adults With Chronic Indeterminate Chagas Disease (FEXI12)

Chagas' Disease (Chronic) Nos

Spain
AB Science

Completed

Efficacy and Safety of Masitinib in the Treatment of Progressive Multiple Sclerosis

Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Relapse Free

Poland, Spain, Bulgaria, France, Germany, Greece, Romania
Dr Irma Bernadette S Sitohang

Completed

Oral Glutathione As A Skin Whitening Agent

Glutathione | Skin Whitening

Indonesia
Eurofarma Laboratorios S.A.

Completed

A Non-inferiority, Multicenter and Randomized, Multiple-Dose Study About a Treatment to Hypolactasia (LAILAII)

Lactose Intolerance

Brazil
Galapagos NV
PRA Health Sciences

Completed

Bioavailability Study With GLPG1972

Osteoarthritis

Netherlands
Lexicon Pharmaceuticals

Completed

A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome

Irritable Bowel Syndrome

United States
Janssen Research & Development, LLC

Completed

A Study to Assess the Relative Oral Bioavailability and Food Effect of Single-dose of JNJ-64417184 in Healthy Participants

Healthy

United States
Assiut University

Unknown

Assessment of Early Outcomes of Roflumilast in Patients With Non Cystic Fibrosis Bronchiectasis

Bronchiectasis
Johns Hopkins University

Completed

The Effectiveness of Roflumilast in Improving Mucociliary Clearance in Patients With COPD and Chronic Bronchitis

Emphysema | COPD | Chronic Bronchitis
AstraZeneca
Mitsubishi Tanabe Pharma Corporation

Completed

Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 71 y) (APTA-2217-07)

Bronchial Asthma

Japan
AstraZeneca
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-06)

Chronic Obstructive Pulmonary Disease (COPD)

Japan
Laval University
Takeda; Innovair

Terminated

Impact of Roflumilast on Visceral Adiposity and Metabolic Profile in Chronic Obstructive Pulmonary Disease (RAMBO)

Chronic Obstructive Pulmonary Disease | Metabolic Syndrome

Canada
Al-Azhar University

Not yet recruiting

Sildenafil Added Effect in Dapoxetine Non-responding Mono-symptomatic Premature Ejaculation (PE) (PE)

Premature Ejaculation
Prof. Dr. Umar Farooq
Ayub Medical College, Abbottabad

Unknown

Effectiveness of Hydroxychloroquine in Covid-19 Patients (Covid)

COVID19

Pakistan
The Mind Research Network

Terminated

Laboratory Screening of Lorcaserin for Alcohol Use Disorder

Tobacco Smoking | Alcohol Use Disorder

United States
Eisai Inc.

Recruiting

A Study to Evaluate Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Participants With Childhood Epilepsy

Partial-onset Seizures | Pediatric Epileptic Syndrome

United States, Spain, France, Belgium, Czechia, Denmark, Germany
Aclaris Therapeutics, Inc.

Terminated

Study of ATI-450 vs Placebo in Patients With Moderate to Severe Psoriatic Arthritis

Psoriatic Arthritis

United States, Poland

Search clinical trials for: Roflumilast Oral Tablet

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations